Stericycle (Nasdaq: SRCL) reported earnings on April 24. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), Stericycle met expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded. Non-GAAP earnings per share increased. GAAP earnings per share expanded.

Gross margins shrank, operating margins were steady, net margins grew.

Revenue details
 Stericycle booked revenue of $513.8 million. The 12 analysts polled by S&P Capital IQ anticipated sales of $520.1 million on the same basis. GAAP reported sales were 12% higher than the prior-year quarter's $460.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.88. The 15 earnings estimates compiled by S&P Capital IQ averaged $0.88 per share. Non-GAAP EPS of $0.88 for Q1 were 13% higher than the prior-year quarter's $0.78 per share. GAAP EPS of $0.85 for Q1 were 13% higher than the prior-year quarter's $0.75 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 45.2%, 170 basis points worse than the prior-year quarter. Operating margin was 26.2%, much about the same as the prior-year quarter. Net margin was 14.5%, 40 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $530.9 million. On the bottom line, the average EPS estimate is $0.91.

Next year's average estimate for revenue is $2.13 billion. The average EPS estimate is $3.69.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 298 members out of 326 rating the stock outperform, and 28 members rating it underperform. Among 95 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 86 give Stericycle a green thumbs-up, and nine give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Stericycle is outperform, with an average price target of $106.38.

Looking for alternatives to Stericycle? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.